Skip to main content
. 2021 May 14;41(3):362–370. doi: 10.1002/npr2.12183

TABLE 2.

Patient primary, secondary and tertiary diagnoses

Diagnosis

Primary

n (%)

Secondary

n (%)

Tertiary

n (%)

Chronic pain of undefined etiology 48 (37.2%) 12 (9.3%) 3 (2.3%)
Neuropathic pain 22 (17.1%) 13 (10.1%) 2 (1.6%)
Anxiety 11 (8.5%) 13 (10.1%) 4 (3.1%)
Fibromyalgia 8 (6.2%) 11 (8.5%) 1 (0.8%)
Ehlers–Danlos 7 (5.4%) 5 (3.9%) 2 (1.6%)
PTSD 7 (5.4%) 1 (0.8%) 0 (0.0%)
Palliative care 6 (4.7%) 0 (0.0%) 0 (0.0%)
Epilepsy adult 4 (3.1%) 1 (0.8%) 0 (0.0%)
Migraine 3 (2.3%) 2 (1.6%) 5 (3.9%)
Depression 3 (2.3%) 2 (1.6%) 4 (3.1%)
Insomnia 2 (1.6%) 3 (2.3%) 2 (1.6%)
Headache 2 (1.2%) 0 (0.0%) 0 (0.0%)
Autistic spectrum disorder 1 (0.8%) 2 (1.6%) 1 (0.8%)
Crohn's Disease 1 (0.8%) 1 (0.8%) 0 (0.0%)
OCD 1 (0.8%) 1 (0.8%) 0 (0.0%)
Complex regional pain syndrome 1 (0.8%) 0 (0.0%) 0 (0.0%)
Multiple sclerosis 1 (0.8%) 0 (0.0%) 0 (0.0%)
Parkinson's 1 (0.8%) 0 (0.0%) 0 (0.0%)
Agoraphobia 0 (0.0%) 1 (0.8%) 0 (0.0%)
Cancer pain 0 (0.0%) 3 (2.3%) 0 (0.0%)
Cluster headaches 0 (0.0%) 1 (0.8%) 0 (0.0%)
Ulcerative colitis 0 (0.0%) 1 (0.8%) 0 (0.0%)
Chemotherapy induced nausea and vomiting 0 (0.0%) 0 (0.0%) 1 (0.8%)
Eating Disorder 0 (0.0%) 0 (0.0%) 1 (0.8%)